CDEK by Data4ThePeople
IndicationsMechanismsTrialsFDA ApprovalsAbout
Sign in Sign up
IndicationsMechanismsTrialsFDA ApprovalsAbout

Chapter 2 - Neoplasms (C00-D49)»Benign neoplasms, except benign neuroendocrine tumors (D10-D36)»Benign lipomatous neoplasm (D17)

D17

Benign lipomatous neoplasm

Sub-codes (9)

  • D17.0 Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck
  • D17.1 Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk
  • D17.2 Benign lipomatous neoplasm of skin and subcutaneous tissue of limb
  • D17.3 Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites
  • D17.4 Benign lipomatous neoplasm of intrathoracic organs
  • D17.5 Benign lipomatous neoplasm of intra-abdominal organs
  • D17.6 Benign lipomatous neoplasm of spermatic cord
  • D17.7 Benign lipomatous neoplasm of other sites
  • D17.9 Benign lipomatous neoplasm, unspecified

    1 indication for 7 drugs

CDEK

The Clinical Drug Experience Knowledgebase — tracking drugs, sponsoring organizations, and clinical trials from first-in-human testing through approval.

Browse

  • Drugs
  • Organizations
  • Trials

About

  • About CDEK
  • Glossary

Built and maintained by Data4ThePeople.

YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED "AS IS", WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.